Core Viewpoint - Amneal Pharmaceuticals (AMRX) has shown a significant price increase of 13.8% over the past four weeks, with a mean price target of $12 indicating a potential upside of 27.7% from its current price of $9.4 [1] Price Targets and Analyst Consensus - The average price target for AMRX ranges from a low of $11.00 to a high of $13.00, with a standard deviation of $0.82, suggesting a relatively tight clustering of estimates [2] - The lowest estimate indicates a 17% increase from the current price, while the highest estimate points to a 38.3% upside [2] - A low standard deviation indicates strong agreement among analysts regarding the stock's price movement direction [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about AMRX's earnings prospects, as evidenced by a positive trend in earnings estimate revisions [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 8.9%, with three estimates moving higher and no negative revisions [12] - AMRX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Implications of Price Targets - While the consensus price target may not be a reliable indicator of the stock's potential gain, it does provide a directional guide for further research [14]